A double-blind placebo-controlled study of Hexopal in the treatment of intermittent claudication.
D000368:Aged; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005080:Exercise Test; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D008297:Male; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010352:Patient Dropouts; D005082:Physical Exertion / Q000187:drug effects; D011897:Random Allocation; D013997:Time Factors; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014665:Vasodilator Agents; C005193:Inositol Niacinate